350561 <common-name>[3,5-bis(trifluoromethyl)phenyl]-[(2r)-2-(1h-indol-3-ylmethyl)-4-[[5-(morpholin-4-ylmethyl)-2h-triazol-4-yl]methyl]piperazin-1-yl]methanone</common-name> <description>[3,5-bis(trifluoromethyl)phenyl]-[(2r)-2-(1h-indol-3-ylmethyl)-4-[[5-(morpholin-4-ylmethyl)-2h-triazol-4-yl]methyl]piperazin-1-yl]methanone is a chemical compound with the formula C30H31F6N7O2. With an average molecular weight of 635.60 g/mol, [3,5-bis(trifluoromethyl)phenyl]-[(2r)-2-(1h-indol-3-ylmethyl)-4-[[5-(morpholin-4-ylmethyl)-2h-triazol-4-yl]methyl]piperazin-1-yl]methanone is a heavy molecule.</description> <cas>393101-98-9</cas> <pubchem-id>11635932</pubchem-id> <chemical-formula>C30H31F6N7O2</chemical-formula> <weight>635.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:42:21Z</created-at> <updated-at type="dateTime">2026-08-31T15:42:21Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1CN(C(CN1CC2=NNN=C2CN3CCOCC3)CC4=CNC5=CC=CC=C54)C(=O)C6=CC(=CC(=C6)C(F)(F)F)C(F)(F)F</moldb-smiles> <moldb-formula>C30H31F6N7O2</moldb-formula> <moldb-inchi>InChI=1S/C30H31F6N7O2/c31-29(32,33)21-11-19(12-22(14-21)30(34,35)36)28(44)43-6-5-42(16-23(43)13-20-15-37-25-4-2-1-3-24(20)25)18-27-26(38-40-39-27)17-41-7-9-45-10-8-41/h1-4,11-12,14-15,23,37H,5-10,13,16-18H2,(H,38,39,40)/t23-/m1/s1</moldb-inchi> <moldb-inchikey>SXASYKWUZQHLET-HSZRJFAPSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">635.2443422</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>3.8</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346454</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>[3,5-bis(trifluoromethyl)phenyl]-[(2r)-2-(1h-indol-3-ylmethyl)-4-[[5-(morpholin-4-ylmethyl)-2h-triazol-4-yl]methyl]piperazin-1-yl]methanone</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Benzene and substituted derivatives</klass> <subklass>Trifluoromethylbenzenes</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300866</sync-id> <structure-inchikey>SXASYKWUZQHLET-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>2080000000210000000000000000000000000000002000000000000000000100800000000800a00000000000000020002000000000000000100000000000400000000000000800002080000000000000000000100200000000800003400000000000000010000001000006010002000000000000000010000000000000001080008020000000000200000080010408000000000008000000000000000000000405000008400004004000004004000000800000800040000000800004000000010000000000000000000000000000000000020004000101000000000000004000004100004000040080c000000000000000080000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAtAAAAMgAAAIABBgBgAAAAAgIGAGAAAAAC AgcAKAAAAAMDBgBgAAAAAwEGAGAAAAACAgcAIAAAAAMGAGAAAAACAgZAKAAA AAMEB0AoAAAAAwMHQDgAAAADAQMHQCgAAAADAwZAKAAAAAMEBgBgAAAAAgIH ACAAAAADBgBgAAAAAgIGAGAAAAACAggAIAAAAAIGAGAAAAACAgYAYAAAAAIC BgBgAAAAAgIGQCgAAAADBAZAaAAAAAMDAQdAOAAAAAMBAwZAKAAAAAMEBkBo AAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGACgA AAADBAgAKAAAAAMCBkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMD AQZAKAAAAAMEBkBoAAAAAwMBBgAgAAAABAkAIAAAAAEJACAAAAABCQAgAAAA AQYAIAAAAAQJACAAAAABCQAgAAAAAQkAIAAAAAELAAEAAQIAAgMAAwQABAUA BQYABgcABwhoDAgJaAwJCmgMCgtoDAsMAAwNAA0OAA4PAA8QABARABESAAMT ABMUABQVaAwVFmgMFhdoDBcYaAwYGWgMGRpoDBobaAwbHGgMAh0gHR4oAh0f IB8gaAwgIWgMISJoDCIjaAwjJGgMIyUAJSYAJScAJSgAISkAKSoAKSsAKSwA BQAACwdoDBINABwUaAwcF2gMJB9oDEIGAAAABgAFBAMCAQUIBwsKCQYODxAR Eg0FFRQcFxYGGBkaGxwXBiAhIiMkHxcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:33Z</structure-indexed-at> </compound>